Day: June 8, 2020

QPR SOFTWARE OYJ PÖRSSITIEDOTE 8.6.2020 KLO 14:00QPR SOFTWARE OYJ:N VARSINAISEN YHTIÖKOKOUKSEN PÄÄTÖKSET JA HALLITUKSEN JÄRJESTÄYTYMISKOKOUSQPR Software Oyj:n varsinaisessa yhtiökokouksessa 8.6.2020 tehtiin seuraavat päätökset:TILINPÄÄTÖKSEN VAHVISTAMINEN, HALLITUKSEN JÄSENTEN JA TOIMITUSJOHTAJAN VASTUUVAPAUSYhtiökokous vahvisti yhtiön tilinpäätöksen konsernitilinpäätöksineen tilikaudelta 1.1.–31.12.2019 sekä myönsi vastuuvapauden hallituksen jäsenille ja toimitusjohtajalle.OSINKOYhtiökokous päätti hallituksen esityksen mukaisesti, että tilikaudelta 2019 ei jaeta osinkoa.PALKITSEMISPOLITIIKKAYhtiökokous teki yhtiön toimielinten palkitsemispolitiikasta neuvoa-antavan päätöksen, ja päätti kannattaa esitettyä palkitsemispolitiikkaa.HALLITUKSEN JÄSENTEN PALKKIOTYhtiökokous päätti pitää hallitustyöskentelystä maksettavat palkkiot ennallaan....

AUSTIN, Texas, June 08, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading provider of professional testing, inspection, engineering, program management and consulting services, announced today that Joe Boyer, CEO, and David Quinn, CFO, will present at the Stifel 2020 Virtual Cross Sector Insight Conference on Wednesday, June 10, 2020 at 4:00 p.m. Eastern Time.A live audio webcast will be available at the time of the event and may be accessed through the Investors section of the Company’s website at https://www.oneatlas.com.  A replay of the audio webcast will be available after the event.About Atlas Technical ConsultantsHeadquartered in Austin, Texas, Atlas is a leading provider of professional testing, inspection engineering and consulting services under the name Atlas...

LONDON, Ontario, June 08, 2020 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce its financial and operating results for first quarter fiscal 2020 ended March 31, 2020. All figures are reported in Canadian dollars ($), unless otherwise indicated. Indiva’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). For a more comprehensive overview of the corporate and financial highlights presented in this press release, please refer to Indiva’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three Months Ended March 31, 2020, and the Company’s Condensed Consolidated Interim Financial Statements for the Three Months Ended March 31, 2020 and 2019, which are...

TORONTO, June 08, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that it has today closed a private placement with an institutional investor (the “Investor”), for aggregate gross proceeds of $37,822,500 (the “Offering”). All dollar amounts in this news release are in Canadian dollars.$18,911,250 of the Offering is related to the placement of a $20.5 million unsecured convertible note (the “First Note”) and a warrant (the “First Warrant”) to purchase up to 3,601,427 common shares of the Company (the “Common Shares”); and $18,911,250 of the Offering is currently being held in escrow and is related to the placement...

SALT LAKE CITY, June 08, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today a newly published study in Psychiatry Research. The study demonstrated the GeneSight® Psychotropic test is better at predicting citalopram and escitalopram blood concentrations when compared to single-gene testing.The GeneSight test uses a combinatorial pharmacogenomic approach, which evaluates how variations in multiple genes may influence an individual’s outcomes with certain medications.“The GeneSight test assesses and weighs multiple gene factors, which more accurately predicts blood drug levels and identifies more patients with significant gene-drug interactions who would be missed by single-gene testing,” said Michael R. Jablonski, Ph.D., vice president of medical...

CALGARY, Alberta, June 08, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) today reported that Mr. Barry Eccleston, former President and CEO of Airbus America has agreed to serve as Executive Chairman of the Board of FLYHT and will help guide the Company utilizing his strong relationships with customers, suppliers and OEMs in the commercial aviation and defense industries. Mr. Eccleston has enjoyed a 40+ year storied career as an aerospace visionary and proponent of the advancement and development of the aviation industry. Mr. Bill Tempany, former CEO of FLYHT,  will serve as the interim Chief Executive Officer while the Company recruits a permanent replacement.  Mr. Tempany will also continue to serve as a director of the Company.The Company has terminated the contract...

DETROIT, June 08, 2020 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC), a leading global supplier of vehicle cockpit electronics, will present at Deutsche Bank’s 2020 Global Auto Industry Conference on Thursday, June 11. Sachin Lawande, president and CEO, and Jerome Rouquet, senior vice president and chief financial officer, will present starting at approximately 8:30 a.m. ET and participate in a question-and-answer session. The presentation and Q&A session are expected to last approximately 35 minutes.A live audio webcast, along with the presentation material and other supplemental information, will be accessible through Visteon’s website at https://investors.visteon.com/events-presentations. A replay will be available following the event.About VisteonVisteon is a global technology company that designs, engineers and manufactures...

SÃO PAULO, Brazil, June 08, 2020 (GLOBE NEWSWIRE) — XP Inc. (Nasdaq: XP), a leading, technology-driven financial services platform and a trusted provider of low-fee financial products and services in Brazil, announces the acquisition of a majority ownership stake in Fliper, an automated investment consolidation platform that offers its users connectivity and tools to perform intuitive and intelligent financial self-management. The transaction allows XP Inc. to offer its customers additional resources to manage their investments, as the open banking trend continues to accelerate in Brazil.The acquisition is part of XP Inc.’s growth strategy and reinforces the value that the company sees in innovative fintechs, constantly seeking to attract the best entrepreneurs to complement and improve its investment platform. Fliper’s founders...

-PBCAR269A Targets BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma and is the Company’s Third Investigational Allogeneic CAR T Candidate Advanced to the Clinic –-PBCAR269A is the First Off-the-Shelf Candidate Produced at In-House Manufacturing Center-DURHAM, N.C., June 08, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced that the first patient has been dosed in a Phase 1/2a clinical trial of PBCAR269A, its third allogeneic chimeric antigen receptor (CAR) T cell therapy candidate. Wholly-owned by Precision, PBCAR269A targets the B-cell maturation antigen (BCMA) and is being evaluated for the treatment of relapsed/refractory multiple myeloma. “PBCAR269A...